U.S. Software Stock News

In recent news, Voyager Technologies raised its full-year 2025 sales guidance to the upper end of its US$165 million to US$170 million range, citing strong performance from recent acquisitions and substantial defense segment growth. This announcement underscores the company's focus on execution and expansion, exemplified by continued momentum in its government and commercial partnerships despite sector volatility. We will explore how Voyager Technologies' upgraded sales outlook and robust...

Gibraltar Industries reported third-quarter and nine-month 2025 results on October 30, showing higher sales year-over-year but shifting from net income to a US$89.06 million net loss for the quarter and a US$41.94 million net loss for the year to date. Despite increased revenues, the swing to losses and more cautious full-year earnings guidance highlighted underlying profitability challenges and raised questions about the sustainability of recent operational improvements. We'll now explore...

Wondering if Gambling.com Group is a golden opportunity trading below its fair value, or if the recent turbulence has put the stock in the bargain bin? Let’s take a closer look at what is really behind the current price. Shares have slipped by 6.7% over the last week and are down a hefty 54.6% year-to-date, highlighting how much sentiment and perceived risk can shift for this stock. Ongoing discussions surrounding digital gambling legislation and increased competition in the affiliate...

Fortune Brands Innovations reported its third quarter 2025 results, showing quarterly sales of US$1,149.2 million and net income of US$70.8 million, both down compared to the same period last year, and reaffirmed its guidance for flat to a 2% decline in full-year net sales. An interesting detail is that the company completed a previously announced share repurchase program earlier in the year but did not buy back any shares during the latest quarter, and recent insider selling activity was...

SunOpta Inc. recently reported improved third quarter results, turning a profit, and raised its revenue guidance for 2025 to US$812 million–US$816 million, while also providing a 2026 revenue outlook of US$865 million–US$880 million. This upward revision in guidance, combined with year-over-year sales growth and positive earnings, highlights strengthened operations and management’s confidence in future performance despite a third quarter impairment charge. We’ll assess how SunOpta’s...

Cidara Therapeutics recently announced progress in its Phase 3 ANCHOR study for CD388, securing a US$45 million milestone payment from Janssen, a BARDA award valued up to US$339.2 million to support manufacturing, and receiving FDA Breakthrough Therapy designation. These updates highlight the growing validation and financial support behind CD388, a promising immunotherapeutic candidate for influenza prevention and serious diseases. We'll explore how the combination of clinical and funding...

Porch Group, Inc. recently reported third-quarter 2025 results, surpassing expectations with US$118.08 million in revenue, while raising its full-year adjusted EBITDA and gross profit guidance. This performance was driven by particularly strong results in the Insurance Services segment and management's emphasis on surplus growth and premium scaling, positioning the company for improved future profitability. We'll explore how the company’s upgraded financial outlook and insurance-driven...

Prelude Therapeutics (PRLD) is shaking up its strategy with news of a major exclusive option agreement with Incyte and a renewed focus on its KAT6A breast cancer program. The company is also pausing the SMARCA2 clinical effort. See our latest analysis for Prelude Therapeutics. Prelude’s string of announcements, including the Incyte partnership, SMARCA2 pause, and executive change, has made for a volatile stretch, with the stock tumbling 25% over the last week alone. Share price momentum...

If you have ever wondered whether Viatris is a bargain or just another pharmaceutical stock, you are in the right place. Viatris shares have fluctuated lately, with a 1.5% uptick over the last month but still down 18.5% for the year. Investors are clearly reassessing the story here. Recent headlines around Viatris have focused on its ongoing restructuring plans, including divesting some non-core assets and simplifying its operations. This adds more intrigue to why the price has moved the way...

Curious if ADMA Biologics is actually a bargain or just another biotech story catching attention? You’re not the only one watching for signs of value in this dynamic stock. Despite a rocky patch lately, with shares down 6.2% over the last week and 35.8% in the past year, ADMA Biologics still sports massive long-term gains of 656.2% over five years. Recent headlines highlight ongoing interest in the company’s plasma-derived therapies and new product expansion, with news of expanded FDA...

Caris Life Sciences recently raised its full year 2025 revenue guidance to between US$720.0 million and US$730.0 million, forecasting growth of 75% to 77% over 2024, following a strong third quarter that marked a shift from net loss to net profit with revenue more than doubling year-over-year. This strong performance was accompanied by an amended bylaw requiring shareholders to own at least 3% of outstanding shares to initiate derivative proceedings, signaling a potential change in corporate...

SIGA Technologies (SIGA) just released its third quarter 2025 earnings, showing revenue that dropped sharply from last year and moving into a net loss for the period. Interestingly, results for the first nine months paint a much stronger picture. Both revenue and net income are well above last year’s levels. See our latest analysis for SIGA Technologies. The disappointing third quarter numbers came after a string of stronger results earlier in the year, and the share price reacted swiftly,...

Ingersoll Rand Inc. recently announced its third quarter 2025 results, reporting sales of US$1,955 million and net income of US$244.1 million, both higher than the same period last year, along with updates to its share repurchase program and full year revenue guidance. An interesting detail is that, despite growth in third quarter results, net income for the first nine months was substantially lower year over year, highlighting variability across reporting periods. We’ll examine how...

Neptune Insurance Holdings (NP) has caught investor attention this week, with shares closing at $26.86 and posting a 6% gain for the day. The stock’s recent move stands out against a backdrop of mixed performance within the insurance sector. See our latest analysis for Neptune Insurance Holdings. With a 1-day share price return of 6.2% and a year-to-date gain of 8.3%, Neptune Insurance Holdings is showing signs of renewed momentum following a modest dip over the past month. The latest uptick...

MNTN, Inc. reported its first quarterly profit in four years for the third quarter of 2025, with sales reaching US$70.02 million and net income of US$6.44 million, alongside the launch of QuickFrame AI, an innovative video production platform powered by artificial intelligence. A key insight is the company’s accelerating shift toward small business customers, now representing 15% of revenue, suggesting expanding market reach beyond its traditional base. We'll explore how MNTN's debut of...

Curious if Gogo is undervalued or just misunderstood? You are not alone in wondering if now could be a smart time to look closer at the stock. The share price has taken a hit lately, dropping 16% in just the past week and sliding nearly 17% over the last month, putting some growth-watchers on alert for both risk and potential upside. One of the drivers behind these moves is the recent announcement about Gogo's partnership expansions in inflight connectivity, which has grabbed the attention...

Chart Industries reported its third quarter 2025 earnings on October 29, 2025, showing sales of US$1.10 billion but moving from net income of US$69 million to a net loss of US$138.5 million compared to the same period last year. Despite higher revenues, the company's earnings update revealed a shift to losses, with losses per share replacing the previous year's profits. We'll explore how the shift from profit to net loss may shape the outlook for Chart Industries' investment...

Alexander & Baldwin, Inc. recently amended its US$450 million revolving credit facility, adding a new term loan facility of up to US$200 million, and raised its 2025 earnings guidance to a range of US$0.95 to US$1 per diluted share. These developments point to a focus on both financial flexibility and growth opportunities, particularly as the company actively searches for acquisitions in Hawaii’s competitive investment market. Let's examine how the creation of this new term loan facility...

Reynolds Consumer Products (REYN) stock is attracting renewed attention as recent performance numbers reveal an interesting mix of steady revenue growth and improving net income. Investors are naturally weighing how these trends could influence shares in the months ahead. See our latest analysis for Reynolds Consumer Products. After a choppy start to the year, Reynolds Consumer Products has seen its share price find firmer footing, climbing nearly 9% across the last 90 days as fundamentals...

Alpha and Omega Semiconductor recently released its first quarter earnings for the period ended September 30, 2025, reporting sales of US$182.5 million and a reduced net loss of US$2.12 million compared to the prior year. In addition to improved loss metrics, the company provided revenue guidance of approximately US$160 million, plus or minus US$10 million, for the upcoming quarter and expects interest income to exceed interest expense by US$1 million. We'll explore how the company's...

Heritage Insurance Holdings (HRTG) just announced its third quarter earnings, showing a sharp jump in both net income and earnings per share compared to last year, even though revenue growth was only modest. See our latest analysis for Heritage Insurance Holdings. Investors have clearly taken notice of Heritage Insurance Holdings’ remarkable turn in profitability, as the share price has soared 127.91% year-to-date and delivered a 140.09% total return over the past twelve months. Momentum has...

Wondering if Alvotech is undervalued or if there's a rare opportunity hiding in the recent stock swings? You're not alone. Let's dig into the numbers to see what the market might be missing. Alvotech's share price has been under pressure lately, dropping 35.5% in the last week and declining 61.6% year-to-date. This hints at a dramatic shift in market sentiment. Much of the recent movement can be traced to headlines around regulatory developments and ongoing biosimilar approvals, which have...

Wondering if Easterly Government Properties is a hidden bargain or just a value trap? We are about to break down what really matters when weighing up this stock's price. The share price has not painted a rosy picture recently, slipping by 0.3% in the last week and down a significant 25.2% so far this year. Recent news has put the company in the spotlight as market sentiment shifts around government-backed REITs. Developments tied to federal property leasing and broader commercial real estate...

SelectQuote, Inc. ( NYSE:SLQT ) shareholders might be concerned after seeing the share price drop 18% in the last week...